Most eukaryotic cells rely on localized actin
Figure 1
The effect of AE360 anti-p34 antibody on the nucleation and side binding functions of the Arp2/3 complex. (a) Immunolocalization of the p34 subunit of the Arp2/3 complex using AE360 antibodies. The scale bar indicates 10 m. Inset, an immunoblot showing the immunoprecipitation of the p34 subunit of the Arp2/3 complex from whole cell lysates using AE360 antibodies. Lane 1, AE360 antibodies; lane 2, control beads without IgG; the black mark indicates 36.5 kDa molecular weight marker. (b) Nucleation assay in vitro: 3 M actin (5% pyrene-labeled), 10 nM Arp2/3, and 10 nM GST-VCA (squares, 40:1 ratio of antibodies to Arp2/3) or 2 M actin, 2 nM Arp2/3, 2 nM GST-VCA (circles, 200:1 ratio of antibodies to Arp2/3) were incubated in the presence of either 400 nM AE360 anti-p34 antibodies (closed symbols) or an equal volume of TBS buffer (open symbols) at 22ЊC in polymerization buffer (2 mM Tris [pH 8], 0.2 mM CaCl 2 , 0.02% NaN 3 , 0.2 mM ATP, 0.5 mM DTT, 1 mM EGTA, 2 mM MgCl 2 , and 50 mM KCl). (c) The Arp2/3 complex-actin cosedimentation assays: 4 M F-actin, 0.25 M Arp2/3 complex, 0.25 M antibodies as specified, in 5 mM imidazole (pH 7.0), 50 mM KCl, 1 mM MgCl 2 , 0.2 mM ATP, and 1 mM EGTA. The graph shows the percentage of the Arp2/3 complex that is bound to F-actin phase in nucleation by the Arp2/3 complex. 400 s (circles), and 700 s (triangles) after after 30 min of incubation at 22ЊC in the The Arp2/3 complex (27 nM) and GST-VCA initiation of polymerization in the presence of presence of the respective antibodies. (d) The (100 nM) were added to polymerizing actin (4 500 nM nonimmune IgG (open symbols) or effect of AE360 antibodies on the lag M, 5% pyrene-labeled) at 0 s (squares), AE360 antibodies (closed symbols).
the presence of the N-WASP-derived GST-VCA fragment To determine if AE360 antibodies were directly affecting the branching activity of the Arp2/3 complex, we designed ( Figure 1b) . The side binding activity of the purified complex was evaluated in a sedimentation assay using 4 m an electron microscope-based assay to visualize and quantify the branching activity and filament lengths in the F-actin and 0.25 m Arp2/3 complex, conditions under which the Arp2/3 complex binds to the side of the actin presence of the Arp2/3 complex. In the absence of the Arp2/3 complex (and in the presence of control antibodies filament [5, 14] . Under these conditions, the addition of concentrations of AE360 antibodies equimolar to the at a molar ratio of about 10 molecules of antibody to what would be 1 molecule of the complex in the experimental Arp2/3 complex inhibited the binding of the Arp2/3 complex to actin filaments (Figure 1c ). The addition of presample), actin polymerized as long unbranched filaments (average filament length ϭ 0.53 Ϯ 0.05 m), with the formed actin filaments has been shown to reduce the lag phase of Arp2/3 complex-mediated nucleation, suggesting occasional overlapping of filaments resulting from the negative-staining procedure (Figures 2a,d ). In the presthat the binding of the Arp2/3 complex to the sides of actin filaments promotes nucleation [18, 19, 30] . While ence of the Arp2/3 complex activated by the GST-VCA fragment and control nonimmune IgG, the preparation the nucleation-promoting activity of actin filaments on the Arp2/3 complex was observed in the presence of nonconsisted of many short filaments (average filament length ϭ 0.30 Ϯ 0.01 m), with a 4-fold increase in immune IgG, the addition of AE360 antibodies at a saturating concentration (20 moles antibodies: 1 mole Arp2/3 branching (Figures 2b,d ). However, when the AE360 antibody against p34 was added to the preparation at the same complex) drastically inhibited the ability of actin filaments to stimulate Arp2/3-mediated nucleation and exmolar ratio as the nonimmune IgG used in the control, branching was drastically inhibited and correlated with tended the nucleation lag phase (Figure 1d ). This is consistent with the ability of this antibody to inhibit the the reappearance of longer unbranched filaments (average filament length ϭ 0.53 Ϯ 0.02 m) (Figures 2c,d ). These binding of the Arp2/3 complex to the sides of actin filaments and represents the first direct verification of the results demonstrate that this antibody directly affects the ability of the Arp2/3 complex to bind the sides of actin proposal that side binding of the complex stimulates nucleation [18, 19] .
filaments to form branches and to nucleate filaments. To analyze this further, we used a light microscope assay to mg/ml) into MTLn3 cells totally abolished the cells' ability to extend lamellipods in response to EGF stimulation directly measure the filament number and mass [6, 30] . As shown in Figures 2e-g, AE360 antibody inhibited the ( Figure 3 ). As previously reported [23] , microinjection of control nonimmune IgG did not affect EGF-stimulated ability of the Arp2/3 complex to increase the number of filaments (684 Ϯ 20 filament/field for the control experilamellipod extension. In addition, the overall cell morphology was not significantly affected by either of the ment without anti-p34 antibody, 256 Ϯ 21 filaments/field after the addition of 400 nM AE360 antibody, and 75 Ϯ microinjected antibodies, and the cells remained spread 13 filaments/field for the experiment with 800 nM AE360 antibody present), the number of filaments with branches (64%, 50%, and 15% of branched filaments, respectively), and the total filament mass (4.24 Ϯ 0.24 (100%) , 2.15 Ϯ 0.12 (51%) , and 0.54 Ϯ 0.05 (13%) of rhodamine fluorescence [a.u.]/field, respectively). The addition of equal amounts of nonimmune IgG had no effect on these parameters. Altogether, these results combined to demonstrate that the two functions of the Arp2/3 complex, i.e., nucleation and branching, are linked and provided us with a tool to directly determine the importance of the Arp2/3 complex in free barbed end generation and protrusive force in vivo.
MTLn3 mammary carcinoma cells extend flat circumferential lamellipods within minutes after stimulation with
Inhibition of lamellipod extension after microinjection of AE360 antiepidermal growth factor [20, 21] . These extensions are protrusive activity, since lamellipod extension is totally abolished by the AE360 branch-inhibiting antibodies.
The generation of free barbed ends in cells in response to EGF stimulation was unaffected by the inhibition of Arp2/3 activities with the AE360 antibodies. Previous work has implicated severing by cofilin in the generation of free barbed ends in these EGF-stimulated cells, and the results presented here are consistent with these findings [23, 28] .
Previous work had shown that cross-linking of actin fila- present here indicate that the actin cross-linking proteins present in lamellipods cannot compensate for the branching activity of the Arp2/3 complex since the specific inhibition (Figure 3) . These results are consistent with the proposed of the Arp2/3 complex's branching activity is sufficient importance of the branching activity of the Arp2/3 comto inhibit lamellipod extension, even in the presence of plex for protrusive force. However, unexpectedly, neither free barbed ends. Hence, our results demonstrate that the the location nor the amount of nucleation sites for actin Arp2/3 complex provides the cross-linking activity that is polymerization was significantly altered in EGF-stimurequired to branch polymerizing filaments in the nuclelated cells after microinjection with anti-p34 antibodies ation zone [3, 5, 8, 23] , which is necessary for protrusive (Figure 4 ). This indicates that other pathways exist that force [26] . Additional cross-linking by members of the do not involve the side binding-dependent nucleation filamin family might contribute to structural stability more activity of the Arp2/3 complex for the generation of free distally as the actin network grows and moves centripebarbed ends in response to EGF stimulation. tally relative to the membrane in the advancing lamellipod.
Discussion
We provide here a direct demonstration that the nucleation and branching activities of the Arp2/3 complex are
Conclusions
We have prepared an antibody against the p34 subunit linked. This is in accordance with previous results showing that preformed actin filaments enhance Arp2/3 comof the Arp2/3 complex that specifically inhibits the binding of the complex to the sides of actin filaments. In vitro, plex-mediated nucleation of actin polymerization [18, 19] . Our results support the previous interpretation that the this antibody inhibits the nucleation activity of the Arp2/3 complex, confirming that side binding and nucleation are ability of F-actin to overcome the lag in Arp2/3 nucleation is due to side binding, as proposed by Machesky et al. linked activities. In vivo, the antibody inhibits protrusive activity, but not EGF-stimulated barbed ends, indicat- [18] and Higgs et al. [19] . Altogether, our findings support the original dendritic nucleation model for Arp2/3 coming that the branching activity of the Arp2/3 complex is essential for protrusive force, that other actin cross-linkplex-mediated network formation in which branches are formed by nucleation on the side of an existing actin ing proteins cannot compensate for this activity, and that free barbed ends are not sufficient for protrusive force. filament [5, 30] . Furthermore, our results demonstrate that the generation of nucleation sites for actin polymer-
The failure of the antibody to inhibit the generation of barbed ends in vivo indicates that Arp2/3-independent ization, although necessary [22, 23] , is not sufficient for lamellipod extension. The binding of the Arp2/3 complex pathways are present in EGF-treated cells for the stimulation of actin polymerization. This conclusion is consistent to the sides of the actin filaments and the generation of branches appears, on the other hand, to be essential for with previous work implicating severing by cofilin as the 
Material and methods
was added at the beginning of the polymerization reaction to limit filament
Protein purification
length. Longer filaments significantly complicate quantative analysis of Actin was purified from rabbit skeletal muscle acetone powder, and LM images. Polymerized actin was diluted 1:15 with polymerization buffer the Arp2/3 complex was purified from human platelets [27] . Human and incubated for 5 min over the nitrocellulose-covered coverslip "cham-N-WASP-VCA domain was expressed in bacteria and purified as a GSTber". Unbound actin was washed away with ISAP buffer containing tagged fragment. Pyrene actin was made as previously described [22] .
antibleaching reagents, and images were taken with a CCD camera Polyclonal antibodies against p34 were generated by immunizing rabbits mounted on an Olympus IX70 microscope as previously described [29] . with MAP-peptides with the following sequence: EKKEMKTITGKTFS Four fields of view were randomly captured with a 60ϫ objective from (amino acids 286-298). The IgG fraction was isolated using T-Gel different parts of the slide for every experimental condition. The images (Pierce) and further purified by affinity chromatography against the pepwere analyzed, and filament parameters were scored using NIH Image tide immunogen. Nonimmune rabbit IgGs were obtained from Sigma software. The F-actin mass was scored in arbitrary units based on rhodaand further purified on T-Gel. Immunofluorescence was performed using mine fluorescence intensity. AE360 anti-p34 antibodies followed by FITC-labeled anti-rabbit secondary antibodies as previously described [21] . images processed in NIH Image.
